Thromb Haemost 2009; 102(06): 1278-1280
DOI: 10.1160/TH09-03-0141
Letters to the Editor
Schattauer GmbH

Plasma fibronectin concentration in inbred mouse strains

Bianca Tomasini-Johansson
1   Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA
,
Deane F. Mosher
1   Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA
› Author Affiliations
Further Information

Publication History

Received: 02 March 2009

Accepted after minor revision: 29 September 2009

Publication Date:
28 November 2017 (online)

 

 
  • References

  • 1 Ni H, Yuen PS, Papalia JM. et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA 2003; 100: 2415-2419.
  • 2 Matuskova J, Chauhan AK, Cambien B. et al. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol 2006; 26: 1391-1396.
  • 3 Cho J, Mosher DF. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood 2006; 107: 3555-3563.
  • 4 Cho J, Mosher DF. Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor. Blood 2006; 108: 2229-2236.
  • 5 Houdijk WP, Sakariassen KS, Nievelstein PF. et al. Role of factor VIII-von Willebrand factor and fibronect-in in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest 1985; 75: 531-540.
  • 6 Zerlauth G, Wolf G. Plasma fibronectin as a marker for cancer and other diseases. Am J Med 1984; 77: 685-689.
  • 7 Farrell DH. New risk factor for venous thromboembolism?. Thromb Haemost 2008; 100: 173-174.
  • 8 Pecheniuk NM, Elias DJ, Deguchi H. et al. Elevated plasma fibronectin levels associated with venous thromboembolism. Thromb Haemost 2008; 100: 224-228.
  • 9 Song KS, Kim HK, Shim W. et al. Plasma fibronectin levels in ischemic heart disease. Atherosclerosis 2001; 154: 449-453.
  • 10 Orem C, Durmus I, Kilinc K. et al. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness. Coron Artery Dis 2003; 14: 219-224.
  • 11 Zhang Y, Zhou X, Krepinsky JC. et al. Association study between fibronectin and coronary heart disease. Clin Chem Lab Med 2006; 44: 37-42.
  • 12 Vavalle JP, Wu SS, Hughey R. et al. Plasma fibronectin levels and coronary artery disease. J Thromb Haemost 2007; 05: 864-866.
  • 13 Murphy-Ullrich JE, Oberley TD, Mosher DF. Serologic and pathologic studies of mice immunized with homologous fibronectin. Am J Pathol 1986; 125: 182-190.
  • 14 George EL, Georges-Labouesse EN, Patel-King RS. et al. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993; 119: 1079-1091.
  • 15 Cseh K, Anderlik P, Szeri I. et al. Plasma fibronectin concentration in germfree and conventional mice of various age. Acta Microbiol Hung 1989; 36: 3-6.
  • 16 Zardi L, Cecconi C, Barbieri O. et al. Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells. Cancer Res 1979; 39: 3774-3779.
  • 17 Peters LL, Cheever EM, Ellis HR. et al. Largescale, high-throughput screening for coagulation and hematologic phenotypes in mice. Physiol Genomics 2002; 11: 185-193.
  • 18 Cho J, Mosher DF. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 2006; 04: 1461-1469.